Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: J Community Support Oncol. 2015 Jan;13(1):14–21. doi: 10.12788/jcso.0101

TABLE 1.

Demographics stratified by control and treatment group

Group, n (%)
Variable Control (n = 35) Treatment (n = 45) P
Categorical
Male 30 (85.1) 39 (87.1) .48
White 31 (88.6) 40 (87.9) .20
Urban setting 27 (76.5) 36 (79.1) .10
Tumor stage .33
 I 5 (14.2) 7 (16.3)
 II 12 (34.2) 15 (33.8)
 III 9 (26.9) 13 (29.0)
 IV 3 (9.5) 4 (9.6)
 In situ 1 (2.1) 1 (1.2)
 Unknown 5 (14.2) 5 (10.1)
Radiation 31 (85.7) 41 (91.1) .79
Chemotherapy 20 (57) 33 (73.3) .13
Surgery 4 (11.4) 4 (8.9) .69
Site .15
 Oral cavity 6 (17.1) 8 (16,7)
 Pharynx 10 (29.5) 14 (31.1)
 Larynx 11 (30.1) 13 (29.0)
 Salivary glands 3 (9.5) 4 (9.6)
 Paranasal sinuses 1 (2.1) 1 (1.2)
 Angiosarcoma 1 (2.1) 1 (1.2)
 Unknown 1 (2.1) 5 (10.1)
Continuous
Mean age, y (SD) 59.67 (11.8) 60.73 (10.2) .20
Mean BMI, kg/m2 (SD) 28.1 (8.4) 26.9 (7.6) .82